FIELD: medicine.
SUBSTANCE: invention relates to application of formula (I) compound, for preparation of medication, used for treatment of chronic obstructive pulmonary disease. In compound (I) A represents aryl group, selected from phenyl; B represents aryl group, selected from phenyl or pyridyl; X represents carbon atom or nitrogen atom; R represents substituted or non-substituted groups, selected from heteroaryl groups, including pyridyl, thienyl, furyl, pyrrolyl, pyrazolyl, oxazolyl, thiazolyl, imidazolyl, thiadiazolyl, triazolyl, tetrazolyl, pyrimidinyl and pyrazinyl, and heterocyclic groups, including morpholine, thiomorpholine, piperazine, piperidine, piperidin-4-one, pyrrolidine, pyrrole-2,5-dione, thiazolidine, 1-oxido-thiazolidine and 1,1-dioxido-1,3-thiazolidine; where heterocyclic group is optionally substituted with substituents, independently selected from substituted or non-substituted (C6)aryl, -CH2-C6aryl, -CH2-heteroaryl, CO-C6aryl, -CO-heteroaryl, -CS-heteroaryl, -CO-C3-6cycloalkyl, cyano(C1-4)alkyl, -O-methyloxime, -SO2Cl, formyl, or other substituted or non-substituted heterocyclic group, selected from pyridyl, pyrimidinyl and piperidinyl; where binding of heterocyclic group to pyrimidine ring takes place through carbon or nitrogen atom; and where group R or substituent of heterocyclic group R are optionally substituted. Other substituents are given in invention formula.
EFFECT: compounds are suitable for treatment of immunological diseases, inflammation, pain impairment, rheumatoid arthritis; osteoporosis, multiple myeloma, uveitis, acute and chronic myelogenous leukaemia; atherosclerosis, cancer, cachexia and other diseases.
15 cl, 15 tbl, 158 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED ARYLAMINES AND THEIR APPLICATION AS 5-HT-RECEPTOR MODULATORS | 2006 |
|
RU2440996C2 |
AZETIDINYL DIAMIDES AS MONOACYLGLICEROL LIPASE INHIBITORS | 2010 |
|
RU2569298C2 |
NOVEL ARYLPIPERAZINYL COMPOUNDS | 2004 |
|
RU2339627C2 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LYPASE INHIBITORS | 2010 |
|
RU2549547C2 |
THIENO[3,2-d]PYRIMIDINE DERIVATIVES WITH PROTEIN KINASE INHIBITORY ACTIVITY | 2012 |
|
RU2705577C2 |
NEW DERIVATIVES OF 5, 7-DISUBSTITUTED [1, 3] THIAZOLO[4, 5-D] PYRIMIDINE-2(3H)-ONE | 2006 |
|
RU2411245C9 |
NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME FOR TREATMENT OF INFLAMMATORY DISORDERS | 2014 |
|
RU2675818C2 |
NEW PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (1) | 2005 |
|
RU2330021C2 |
COMPOSITIONS SUITABLE FOR TREATING DISORDERS ASSOCIATED WITH KIT | 2014 |
|
RU2706235C2 |
Authors
Dates
2016-01-20—Published
2009-01-30—Filed